Related Experiment Videos
Clinical trial of young red blood cells prepared by apheresis
Insights
Young red blood cells (YRBC) transfusions did not decrease iron loading in children with thalassemia, despite slightly longer intervals between transfusions. Their effectiveness was lower than predicted.
Area of Science:
- Hematology
- Transfusion Medicine
- Pediatric Thalassemia Research
Background:
- Transfusion-dependent thalassemia requires frequent red blood cell transfusions.
- Iron overload is a major complication of chronic transfusions.
- Young red blood cells (YRBC) are hypothesized to improve transfusion efficacy and reduce iron loading due to prolonged survival.
Purpose of the Study:
- To compare the efficacy of YRBC transfusions prepared by apheresis versus standard washed or frozen red cells in children with thalassemia.
- To evaluate if YRBC transfusions lead to decreased transfusion-associated iron loading.
Main Methods:
- Prospective clinical trial involving five children with transfusion-dependent thalassemia.
- Transfusion of 152 YRBC units, assessed by reticulocyte enrichment and pyruvate kinase activity.
- Comparison of transfusion intervals and iron loading between YRBC and standard red cell transfusion periods.
Main Results:
- A statistically significant, but modest, increase in the interval between transfusions was observed with YRBC (30.0 ± 1.5 days) compared to the period after (27.9 ± 1.1 days).
- No significant decrease in iron transfused per kilogram was associated with YRBC transfusions.
- The in vivo effectiveness of transfused YRBC units was lower than predicted by in vitro and in vivo studies.
Conclusions:
- YRBC transfusions in children with thalassemia did not reduce transfusion-associated iron loading.
- The clinical effectiveness of YRBC transfusions was less than anticipated based on preclinical data.
- Further research is needed to optimize red blood cell transfusion strategies for thalassemia.
Abstract:
Transfusion of young red blood cells (YRBC) with prolonged survival should result in increased intervals between transfusions and, therefore, decreased transfusion-associated iron loading. A prospective clinical trial comparing YRBC transfusions prepared by apheresis versus washed or frozen red cell transfusions was performed in five children with transfusion-dependent thalassemia. A total of 152 YRBC units, evaluated by reticulocyte enrichment and pyruvate kinase activity, were transfused. While a slightly longer interval between transfusions was observed during the time period of YRBC versus the time period after (30.0 +/- 1.5 days versus 27.9 +/- 1.1 days, respectively, p less than 0.02), there was no associated decrease in mg of iron transfused per kg. The effectiveness of transfused YRBC units was less than predicted by in vitro and in vivo studies.